Primary Adenocarcinoma of the Fallopian Tube: Report of Two Cases
- *Corresponding Author:
- Tahiri Elousrouti L
Laboratory of Surgical Pathology
Hospital University Center Hassan II, Fez, Morocco
Tel: +212 5356-19053
E-mail: [email protected]
Received March 28, 2016; Accepted May 11, 2016; Published May 17, 2016
Citation: Tahiri Elousrouti L, Erragad FZ, Jayi S, Hammas N, Harmouch T, et al. (2016) Primary Adenocarcinoma of the Fallopian Tube: Report of Two Cases. J Clin Case Rep 6:792. doi:10.4172/2165-7920.1000792
Copyright: © 2016 Tahiri Elousrouti L, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Primary fallopian tube cancer is the rarest cancer of female genital tract. In fact, it represents less than 1% of all the gynaecological and breast cancers. Adenocarcinoma is the most common histological type. This paper revels two cases of primary fallopian tube adenocarcinoma. They are diagnosed in pathology department. There are two patients to 53 years and 62 years respectively, with no significant personal or family history. They are consulted for chronic pelvic pain with pelvic mass. The clinical assessment revealed an abdomino-pelvic mass of hard consistency. We review the epidemiological, clinical, anatomo-pathological, therapeutic and prognosis specificities of this tumor. This cancer occurs in patients in their sixties, in a context of infertility, pauci-parity, chronic tubal infection or a genetic predisposition. The pelvic pain and the perception of a pelvic mass are the most frequent clinical manifestations. Paraclinical examinations (pelvic ultrasound, CT, MRI and serum markers) are not specific and diagnosis is often made peroperatively or postoperatively by anatomo-pathological examination. In fact, the tubal carcinoma is often confused with his ovarian counterpart which have several similarities. The prognosis is relatively dark, but still better than ovarian carcinoma. It mainly depends on the stage of disease and quality of surgical resection.